|本期目录/Table of Contents|

[1]文照禾 综述,刘力 审校.血液代谢组学在系统性红斑狼疮中的应用进展[J].天津医科大学学报,2023,29(06):677-680.
点击复制

血液代谢组学在系统性红斑狼疮中的应用进展(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
29卷
期数:
2023年06期
页码:
677-680
栏目:
综述
出版日期:
2023-11-20

文章信息/Info

Title:
-
文章编号:
1006-8147(2023) 06-0677-04
作者:
文照禾1; 2 综述; 刘力1 审校
（1.天津市儿童医院综合内科，天津 300070；2.天津医科大学研究生院，天津 3000041）
Author(s):
-
关键词:
系统性红斑狼疮; 血液代谢组学; 生物标志物; 差异代谢物
Keywords:
-
分类号:
R392
DOI:
-
文献标志码:
A
摘要:
系统性红斑狼疮（SLE）是一种发病机制不明，多组织器官受累的慢性自身免疫性疾病，其临床异质性为疾病的诊断和治疗带来困难。代谢组学是研究机体内源性小分子的组学领域，血液代谢物是机体受到基因调控和环境影响后的下游产物，反映了体内的病理生理过程。近年来，血液代谢物在SLE患者和健康人群之间、不同症状SLE患者之间的差异受到越来越多的关注。总结并比较现已发表的应用血液代谢组学对SLE进行的研究，将有助于研究疾病发病机制，开发新的生物标志物用于诊断、鉴别诊断和评估病情进展。
Abstract:
-

参考文献/References:

[1] FAVA A，PETRI M. Systemic lupus erythematosus: diagnosis and clinical management[J]. J Autoimmun，2019，96：1-13.
[2] LETERTRE M P M，DERVILLY G，GIRAUDEAU P. Combined nuclear magnetic resonance spectroscopy and mass spectrometry approaches for metabolomics[J]. Anal Chem，2021，93（1）：500-518.
[3] ZHAO L，HU X，XIAO F，et al. Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus[J]. Front Immunol，2022，13：929520.
[4] WU T，XIE C，HAN J，et al. Metabolic disturbances associated with systemic lupus erythematosus[J]. PLoS One，2012，7（6）：e37210.
[5] HU C，ZHOU J，YANG S，et al. Oxidative stress leads to reduction of plasmalogen serving as a novel biomarker for systemic lupus erythematosus[J]. Free Radic Biol Med，2016，101：475-481.
[6] HU C F，ZHANG J D，HONG S Z，et al. Oxidative stress-induced aberrant lipid metabolism is an important causal factor for dysfunction of immunocytes from patients with systemic lupus erythematosus[J]. Free Radic Biol Med，2021，163：210-219.
[7] OUYANG X，DAI Y，WEN J L，et al. 1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus[J]. Lupus，2011，20（13）：1411-1420.
[8] KIM H A，LEE H S，SHIN T H，et al. Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever[J]. Lupus，2018，27（6）：930-938.
[9] WANG Y Z，GUO F，HAO D L，et al. Nontargeted serum metabolomics analysis and potential biomarkers for systemic lupus erythematosus[J]. Microchem J，2021，170：7.
[10] SHIN T H，KIM H A，JUNG J Y，et al. Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever[J]. Metabolomics，2017，14（1）：14.
[11] BENGTSSON A A，TRYGG J，WUTTGE D M，et al. Metabolic profiling of systemic lupus erythematosus and comparison with primary sj?觟gren′s syndrome and systemic sclerosis[J]. PloS one，2016，11（7）：e0159384.
[12] CHECA A，IDBORG H，ZANDIAN A，et al. Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus：a cross-sectional study[J]. Lupus，2017，26（10）：1023-1033.
[13] LIU J J，ZHANG D Y，WANG K E，et al. Time course of metabolic alterations associated with the progression of systemic lupus erythematosus in mrl/ipr mice based on GC/MS[J]. J Proteome Res，2021，20（2）：1243-1251.
[14] ZHANG W，ZHAO H，DU P，et al. Integration of metabolomics and lipidomics reveals serum biomarkers for systemic lupus erythematosus with different organs involvement[J]. Clin Immunol，2022，241：109057.
[15] XIE Y，LIU B，WU Z. Identification of serum biomarkers and pathways of systemic lupus erythematosus with skin involvement through GC/MS-based metabolomics analysis[J]. Clin Cosmet Investig Dermatol，2022，15：77-86.
[16] BAIG S，VANARSA K，DING H，et al. Baseline elevations of leukotriene metabolites and altered plasmalogens are prognostic biomarkers of plaque progression in systemic lupus erythematosus[J]. Front Cardiovasc Med，2022，9：861724.
[17] ZHANG Y，GAN L，TANG J，et al. Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus[J]. Front Immunol，2022，13：967371.
[18] YAN B，HUANG J，ZHANG C，et al. Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS[J]. Mod Rheumatol，2016，26（6）：914-922.
[19] PATYNA S，B?譈TTNER S，ECKES T，et al. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus[J]. Prostaglandins Other Lipid Mediat，2019，144：106348.
[20] WANG Y，GUO F，GUO Y，et al. Untargeted lipidomics reveals specific lipid abnormalities in systemic lupus erythematosus[J]. Clin Exp Rheumatol，2022，40（5）：1011-1018.
[21] CHEN J，LIU C，YE S，et al. UPLC-MS/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients[J]. Med Comm （2020），2021，2（2）：269-278.
[22] HUANG X，LUU L D W，JIA N，et al. Multi-platform omics analysis reveals molecular signatures for pathogenesis and activity of systemic lupus erythematosus[J]. Front Immunol，2022，13：833699.
[23] HAMMAD S M，HARDEN O C，WILSON D A，et al. Plasma sphingolipid profile associated with subclinical atherosclerosis and clinical disease markers of systemic lupus erythematosus：potential predictive value[J]. Front Immunol，2021，12：694318.
[24] IWASAKI Y，TAKESHIMA Y，NAKANO M，et al. Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis[J]. Rheumatology（Oxford），2023，62（2）：905-913.
[25] GULERIA A，PHATAK S，DUBEY D，et al. NMR-based serum metabolomics reveals reprogramming of lipid dysregulation following cyclophosphamide-based induction therapy in lupus nephritis[J]. J Proteome Res，2018，17（7）：2440-2448.
[26] CALZADA C，VORS C，PENHOAT A，et al. Role of circulating sphingolipids in lipid metabolism：why dietary lipids matter？[J]. Front Nutr，2022，9：1108098.
[27] YAO Y，SCHNEIDER A，WOLF K，et al. Longitudinal associations between metabolites and long-term exposure to ambient air pollution：results from the KORA cohort study[J]. Environ Int，2022， 170：107632.
[28] KASPY M S，SEMNANI-AZAD Z，MALIK V S，et al. Metabolomic profile of combined healthy lifestyle behaviours in humans：a systematic review[J]. Proteomics，2022，22（18）：e2100388.
[29] BORDAG N，KLIE S，J?譈RCHOTT K，et al. Glucocorticoid （dexamethasone）-induced metabolome changes in healthy males suggest prediction of response and side effects[J]. Sci Rep，2015，5：15954.
[30] HAGE M P，AL-BADRI M R，AZAR S T. A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role[J]. Ther Adv Endocrinol Metab，2014，5（4）：77-85.
[31] SUBRAMANIAN S，TRENCE D L. Immunosuppressive agents：effects on glucose and lipid metabolism[J]. Endocrinol Metab Clin North Am，2007，36（4）：891-905.

相似文献/References:

[1]孟繁杰 综述,王广舜 审校.胸腺瘤与自身免疫性疾病的研究进展[J].天津医科大学学报,2021,27(02):195.
[2]李赫,胡坚,刘力.儿童系统性红斑狼疮伴Jaccoud关节病1例并文献复习[J].天津医科大学学报,2022,28(06):672.
[3]左旭,李津.基于生物信息学方法筛选系统性红斑狼疮疾病进展中与先天免疫细胞相关的关键基因[J].天津医科大学学报,2023,29(03):243.
　ZUO Xu,LI Jin.Bioinformatics-based approach to screen key genes associated with innate immune cells in the development of systemic lupus erythematosus[J].Journal of Tianjin Medical University,2023,29(06):243.

备注/Memo

备注/Memo:
基金项目 天津市医学重点学科（专科）建设项目（TJYXZDXK-040A）
作者简介 文照禾，女（1998-），硕士在读，研究方向：风湿免疫；通信作者：刘力，E-mail：may13_cn@126.com。
更新日期/Last Update: 2023-12-01